non-vasoactive

the non-vasoactive drug provided a safe alternative for patients with hypertension.

we sought non-vasoactive agents to minimize potential side effects in elderly patients.

clinical trials evaluated the efficacy of the non-vasoactive compound in treating pulmonary hypertension.

the non-vasoactive medication is often preferred in patients with renal insufficiency.

careful selection of non-vasoactive therapies is crucial in pediatric cardiology.

the study focused on the long-term effects of non-vasoactive interventions on cardiac function.

comparing non-vasoactive and vasoactive agents helped determine the optimal treatment strategy.

the patient responded well to the non-vasoactive treatment without significant hemodynamic changes.

we administered a non-vasoactive sedative to reduce anxiety before the procedure.

the goal was to achieve pain relief with a non-vasoactive analgesic.

the research investigated the role of non-vasoactive pathways in regulating inflammation.